Exposure to nicotine and carcinogens among Southwestern Alaskan native cigarette smokers and smokeless tobacco users

Cancer Epidemiology Biomarkers and Prevention

Volumn 21, Issue 6, 2012, Pages 934-942

  Benowitz, Neal L ^a   Renner, Caroline C ^b   Lanier, Anne P ^b   Tyndale, Rachel F ^c   Hatsukami, Dorothy K ^d   Lindgren, Bruce ^d   Stepanov, Irina ^d   Watson, Clifford H ^e   Sosnoff, Connie S ^e   Jacob III, Peyton ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b ALASKA NATIVE TRIBAL HEALTH CONSORTIUM   (United States)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITY OF MINNESOTA   (United States)

^e CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3' HYDROXYCOTININE; 4 (METHYLNITROSAMINO) 1 (3 PYRIDYL) 1 BUTANONE; 4 (METHYLNITROSAMINO) 4 (3 PYRIDYL) 1 BUTANOL; BIOLOGICAL MARKER; CARCINOGEN; COTININE; NICOTINE; NITROSAMINE; NITROSONORNICOTINE; POLYCYCLIC AROMATIC HYDROCARBON; UNCLASSIFIED DRUG;

ADDICTION; ADULT; ARTICLE; ASH; CANCER INCIDENCE; CANCER RISK; CIGARETTE SMOKING; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOUTH CANCER; PH; POPULATION EXPOSURE; PRIORITY JOURNAL; SMOKELESS TOBACCO; UNITED STATES;

ADULT; ALASKA; CARCINOGENS; FEMALE; HUMANS; INDIANS, NORTH AMERICAN; MALE; NICOTINE; SMOKING; TOBACCO; TOBACCO, SMOKELESS;

EID: 84862860522     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-11-1178     Document Type: Article

References (32)

1. Alaska Native Health Status Report. Alaska Native Tribal Health Consortium. Alaska: Alaska Native Epidemiology Center; 2009 [cited 2009 Mar 23]. Available from: http://www.anthc.org/chs/epicenter/upload/ANHSR.pdf.
2. Renner CC, Enoch C, Patten CA, Ebbert JO, Hurt RD, Moyer TP, et al. Iqmik: a form of smokeless tobacco used among Alaska natives. Am J Health Behav 2005;29:588-94. (Pubitemid 41617842)
3. Department of Health and Human Services PHS. Tobacco use among U.S. racial/ethnic minority groups, African Americans, American Indians and Alaska Natives, Asian Americans and Pacific Islanders, and Hispanics: a report of the Surgeon General (Executive Summary). USDHHS, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Promotion, Office of Smoking and Health. Washington, DC: Government Printing Office; 1998.
4. Centers for Disease Control and Prevention (CDC). Annual smoking attributable mortality, years of potential life lost, and productivity losses-United States, 1997-2001. MMWR Morb Mortal Wkly Rep 2005;54:625-8.
5. Day GE, Provost E, Lanier AP. Alaska native mortality rates and trends. Public Health Rep 2009;124:54-64.
6. Renner CC, Lanier AP, Lindgren B, Jensen J, Patten CA, Parascandola M, et al. Tobacco Use Among South Western Alaska Native People: Products, Patterns of Use and Dependence. Nicotine Tob Res, 2012, in press.
7. Hecht SS. Human urinary carcinogen metabolites: biomarkers for investigating tobacco and cancer. Carcinogenesis 2002;23:907-22. (Pubitemid 34752946)
8. Jacob P III, Havel C, Lee DH, Yu L, Eisner MD, Benowitz NL. Subpicogram per milliliter determination of the tobacco-specific carcinogen metabolite 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in human urine using liquid chromatography-tandem mass spectrometry. Anal Chem 2008;80:8115-21.
9. Jacob P III, Wilson M, Benowitz NL. Determination of phenolic metabolites of polycyclic aromatic hydrocarbons in human urine as their pentafluorobenzyl ether derivatives using liquid chromatography-tandem mass spectrometry. Anal Chem 2007;79:587-98. (Pubitemid 46110634)
10. Jacob P III, Yu L, Duan M, Ramos L, Yturralde O, Benowitz NL. Determination of the nicotine metabolites cotinine and trans-3′- hydroxycotinine in biologic fluids of smokers and non-smokers using liquid chromatography-tandem mass spectrometry: biomarkers for tobacco smoke exposure and for phenotyping cytochrome P450 2A6 activity. J Chromatogr B Analyt Technol Biomed Life Sci 2011;879:267-76.
11. Bernert JT, Alexander JR, Sosnoff CS, McGuffey JE. Time course of nicotine and cotinine incorporation into samples of nonsmokers' beard hair following a single dose of nicotine polacrilex. J Anal Toxicol 2011;35:1-7.
12. Stepanov I, Carmella SG, Briggs A, Hertsgaard L, Lindgren B, Hatsukami D, et al. Presence of the carcinogen N′-nitrosonornicotine in the urine of some users of oral nicotine replacement therapy products. Cancer Res 2009;69:8236-40.
13. Benowitz NL. Cotinine as a biomarker of environmental tobacco smoke exposure. Epidemiol Rev 1996;18:188-204. (Pubitemid 27082089)
14. Benowitz NL, Dains KM, Dempsey D, Yu L, Jacob P III. Estimation of nicotine dose after low-level exposure using plasma and urine nicotine metabolites. Cancer Epidemiol Biomarkers Prev 2010;19:1160-6.
15. SRNT Subcommittee on Biochemical Verification. Biochemical verification of tobacco use and cessation. Nicotine Tob Res 2002;4: 149-59.
16. Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom KO. The Fagerstrom Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire. Br J Addict 1991;86:1119-27.
17. Boyle RG, Jensen J, Hatsukami DK, Severson HH. Measuring dependence in smokeless tobacco users. Addict Behav 1995;20:443-50.
18. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Smokeless tobacco and some tobacco-specific N-nitrosamines. IARC Monogr Eval Carcinog Risks Hum 2007;89:1-592.
19. Richter P, Hodge K, Stanfill S, Zhang L, Watson C. Surveillance of moist snuff: total nicotine, moisture, pH, un-ionized nicotine, and tobacco-specific nitrosamines. Nicotine Tob Res 2008;10:1645-52.
20. O'Connor RJ, Giovino GA, Kozlowski LT, Shiffman S, Hyland A, Bernert JT, et al. Changes in nicotine intake and cigarette use over time in two nationally representative cross-sectional samples of smokers. Am J Epidemiol 2006;164:750-9. (Pubitemid 44522079)
21. Caraballo RS, Giovino GA, Pechacek TF, Mowery PD, Richter PA, Strauss WJ, et al. Racial and ethnic differences in serum cotinine levels of cigarette smokers: Third National Health and Nutrition Examination Survey, 1988-1991. JAMA 1998;280:135-9. (Pubitemid 28498384)
22. Perez-Stable EJ, Herrera B, Jacob P III, Benowitz NL. Nicotine metabolism and intake in black and white smokers. JAMA 1998;280:152-6. (Pubitemid 28498387)
23. Hecht SS, Carmella SG, Murphy SE, Riley WT, Le C, Luo X, et al. Similar exposure to a tobacco-specific carcinogen in smokeless tobacco users and cigarette smokers. Cancer Epidemiol Biomarkers Prev 2007;16:1567-72. (Pubitemid 47294820)
24. Wennmalm A, Benthin G, Granstrom EF, Persson L, Petersson AS, Winell S. Relation between tobacco use and urinary excretion of thromboxane A2 and prostacyclin metabolites in young men. Circulation 1991;83:1698-704.
25. Angstman S, Patten CA, Renner CC, Simon A, Thomas JL, Hurt RD, et al. Tobacco and other substance use among Alaska Native youth in western Alaska. Am J Health Behav 2007;31:249-60.
26. Hurt RD, Renner CC, Patten CA, Ebbert JO, Offord KP, Schroeder DR, et al. Iqmik-a form of smokeless tobacco used by pregnant Alaska natives: nicotine exposure in their neonates. J Matern Fetal Neonatal Med 2005;17:281-9. (Pubitemid 40992330)
27. Luo J, Ye W, Zendehdel K, Adami J, Adami HO, Boffetta P, et al. Oral use of Swedish moist snuff (snus) and risk for cancer of the mouth, lung, and pancreas in male construction workers: a retrospective cohort study. Lancet 2007;369:2015-20. (Pubitemid 46899161)
28. Stepanov I, Villalta PW, Knezevich A, Jensen J, Hatsukami D, Hecht SS. Analysis of 23 polycyclic aromatic hydrocarbons in smokeless tobacco by gas chromatography-mass spectrometry. Chem Res Toxicol 2010;23:66-73.
29. Benowitz NL, Dains KM, Dempsey D, Wilson M, Jacob P. Racial differences in the relationship between number of cigarettes smoked and nicotine and carcinogen exposure. Nicotine Tob Res 2011;13: 772-83.
30. Stanfill SB, Connolly GN, Zhang L, Jia LT, Henningfield JE, Richter P, et al. Global surveillance of oral tobacco products: total nicotine, unionised nicotine and tobacco-specific N-nitrosamines. Tob Control 2011;20:e2.
31. WHO Study Group. The scientific basis of tobacco product regulation. World Health Organ Tech Rep Ser 2007:1-112, back cover.
32. Ashley DL, Burns D, Djordjevic M, Dybing E, Gray N, Hammond SK, et al. The scientific basis of tobacco product regulation. World Health Organ Tech Rep Ser 2008:1-277, 1 p. following 277.